Freenome on Tuesday introduced the launch of its new Sanderson Research, which can use its multiomics platform, together with real-world knowledge, some derived from Oracle Cerner’s Studying Well being Community, to enhance detection and remedy of a number of cancers.
WHY IT MATTERS
San Francisco-based Freenome’s multiomics platform can allow earlier detection of most cancers utilizing a normal blood draw. The corporate makes a speciality of superior computational biology, utilizing machine studying to detect patterns amongst billions of circulating cell-free biomarkers.
The examine will use each conventional and real-world knowledge to generate proof of scientific validation for sure high- and elevated-risk populations, Freenome says, whereas additionally refining the platform’s oncology classification and threat prediction fashions.
The purpose with the Sanderson Research is to construct infrastructure that may bridge the hole between scientific analysis and day-to-day scientific affect, in response to Freenome.
The corporate is growing a wider screening method for oncology that assesses sufferers’ particular person threat. Freenome’s multiomics platform combines tumor and non-tumor indicators with machine studying to detect most cancers in its earliest levels.
Freenome’s scientific research are named for workers’ family members who battled most cancers; the Sanderson Research honors Tim Sanderson, the daddy of a Freenome engineer. It should enroll roughly 8,000 sufferers by means of Freenome’s scientific examine associate community and quite a few regional well being programs throughout the USA.
It should give attention to cancers with vital unmet wants, corresponding to pancreatic and lung most cancers.
Oracle Cerner’s Studying Well being Community – which contains 90 various well being programs nationwide that contribute de-identified scientific trial knowledge – might be a key associate.
As well as, Elligo Well being Analysis will collaborate with LHN members, the corporate says, utilizing present well being knowledge to establish and enroll sufferers considerably quicker than conventional recruitment fashions.
THE LARGER TREND
Cerner first announced its work with Elligo and Freenome on the Sanderson Research this previous Could. “Our long-term purpose is to advance multicancer merchandise into scientific apply to avoid wasting extra lives,” stated Freenome co-founder Riley Ennis on the time.
In collaboration with the Duke Medical Analysis Institute, Cerner launched the Learning Health Network in 2019 with the purpose of automating knowledge assortment from a number of sources, together with digital well being information.
The intention is to allow clinicians to achieve well being insights and information care extra simply and effectively to offer medical researchers quicker and simpler entry to knowledge that may assist them innovate new approaches to well being.
In October 2021, the company announced the creation of Cerner Enviza, an working unit targeted on growing new approaches to knowledge administration for all times sciences analysis and growth of recent therapies and therapies.
ON THE RECORD
“Early most cancers detection with extra handy screening will develop out there therapies with higher outcomes for sufferers,” stated Christy Dueck, vp of Cerner Enviza. “Oracle Cerner is thrilled to be working with Freenome to assist expedite the examine course of, from hospital and well being system readiness to affected person participation and identification. The Studying Well being Community acts as an accelerant by addressing the present problem of the shortage in websites within the conventional clinical-trial mannequin by creating an abundance of sufferers who’re already actively engaged in healthcare.”
“We’re incorporating real-world knowledge with a precision well being mindset on scientific actionability,” Dr. Lance Baldo, chief medical officer at Freenome, stated in a press release. “Our purpose is to establish the best affected person for the best screening exams on the proper time, with clear subsequent steps. We imagine this method will finally save extra lives.”
Twitter: @MikeMiliardHITN
E-mail the author: mike.miliard@himssmedia.com
Healthcare IT Information is a HIMSS publication.
